Maddison, Paul <br/><br/>
The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome.  [electronic resource] 

 -  Journal of neurology, neurosurgery, and psychiatry  Jun 2011 
 - 671-3 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1468-330X 
<br/><br/><label>Standard No.: </label>10.1136/jnnp.2009.197632  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antibodies, Monoclonal, Murine-Derived--therapeutic use<br/>Child<br/>Child, Preschool<br/>Female<br/>Humans<br/>Immunologic Factors--therapeutic use<br/>Lambert-Eaton Myasthenic Syndrome--drug therapy<br/>Male<br/>Middle Aged<br/>Myasthenia Gravis--drug therapy<br/>Protein-Tyrosine Kinases--immunology<br/>Receptor Protein-Tyrosine Kinases--immunology<br/>Receptors, Cholinergic--immunology<br/>Retrospective Studies<br/>Rituximab